Anti-VEGF antibody triggers the effect of anti-PD-L1 antibody in PD-L1(low) and immune desert-like mouse tumors

por Ishikura, Nobuyuki, Sugimoto, Masamichi, Yorozu, Keigo, Kurasawa, Mitsue, Kondoh, Osamu
Publicado 2022

Sustained effect of continuous treatment with bevacizumab following bevacizumab in combination with chemotherapy in a human ovarian clear cell carcinoma xenograft model

por Ishikura, Nobuyuki, Yorozu, Keigo, Kurasawa, Mitsue, Yanagisawa, Mieko, Sugimoto, Masamichi, Yamamoto, Kaname
Publicado 2019

Bevacizumab counteracts VEGF-dependent resistance to erlotinib in an EGFR-mutated NSCLC xenograft model

por Masuda, Chinami, Yanagisawa, Mieko, Yorozu, Keigo, Kurasawa, Mitsue, Furugaki, Koh, Ishikura, Nobuyuki, Iwai, Toshiki, Sugimoto, Masamichi, Yamamoto, Kaname
Publicado 2017